UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 29, 2020 4:30 P.M.

Form:	S-3
CIK: 0001006281 Company Name: Protalix BioTherapeutics, Inc. File Number: 333-237736